English

KIWA BIO-TECH PRODUCTS GROUP CORP

EDGAR

KWBT Report (type unavailable) · filed 2020-06-01

95 filing records in this dataset, filed from 2001-12-28 to 2020-06-01. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

8.64 million USD

2019 Q4 · USD

Exact inputs and evidence

Revenue: 40089457 USD Source
Revenue: 31454271 USD Source

Operating margin

-40.23%

2019 Q4 · %

Exact inputs and evidence

Operating Income: -1185778 USD Source
Operating Income: 2288580 USD Source
Revenue: 40089457 USD Source
Revenue: 31454271 USD Source

Operating cash flow

-122 thousand USD

2019 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 183067 USD Source
Operating Cash Flow: 305134 USD Source

Cash and cash equivalents: 7.97 thousand USD 2019-12-31 Source
Exact value

7965 USD
Long-term debt including current maturities: 1.81 million USD 2015-09-30 Source
Exact value

1807096 USD
Shares outstanding: 82.5 million shares 2019-12-31 Source
Exact value

82531999 shares

Reported share-count change

388.78% · 65.6 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

16885260 shares · 2018-12-31· Source
82531999 shares · 2019-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

40.1 million USD

2019-01-01 – 2019-12-31

Exact inputs and evidence

Revenue: 9542998 USD · 2019-01-01 – 2019-03-31 Source
Revenue: 10924978 USD · 2019-04-01 – 2019-06-30 Source
Revenue: 10986295 USD · 2019-07-01 – 2019-09-30 Source
Revenue: 40089457 USD · 2019-01-01 – 2019-12-31 Source
Revenue: 31454271 USD · 2019-01-01 – 2019-09-30 Source

Net income

-6.64 million USD

2019-01-01 – 2019-12-31

Exact inputs and evidence

Net income: 390623 USD · 2019-01-01 – 2019-03-31 Source
Net income: -2245690 USD · 2019-04-01 – 2019-06-30 Source
Net income: 311217 USD · 2019-07-01 – 2019-09-30 Source
Net income: -6635296 USD · 2019-01-01 – 2019-12-31 Source
Net income: -1543850 USD · 2019-01-01 – 2019-09-30 Source

Operating cash flow

183 thousand USD

2019-01-01 – 2019-12-31

Exact inputs and evidence

Operating cash flow: -539866 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: -1530963 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: -539866 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: 305134 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -1530963 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: 183067 USD · 2019-01-01 – 2019-12-31 Source
Operating cash flow: 305134 USD · 2019-01-01 – 2019-09-30 Source

Capital expenditure

53 thousand USD

2018-01-01 – 2018-12-31

Exact inputs and evidence

Capital expenditure: 1935 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 3488 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 1935 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 4774 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 3488 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 52992 USD · 2018-01-01 – 2018-12-31 Source
Capital expenditure: 4774 USD · 2018-01-01 – 2018-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-06-01.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2019-12-31
Operating income: 11 of 11 periods available· newest 2019-12-31
Net income: 11 of 11 periods available· newest 2019-12-31
Operating cash flow: 11 of 11 periods available· newest 2019-12-31
Capital expenditure: 6 of 11 periods available· newest 2018-12-31
Total assets: 10 of 11 periods available· newest 2019-12-31
Total liabilities: 10 of 11 periods available· newest 2019-12-31
Current assets: 10 of 11 periods available· newest 2019-12-31
Current liabilities: 10 of 11 periods available· newest 2019-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2019-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2014-12-31
Shares outstanding: 9 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+30.8%

Prior period

USD 30.65 million

2018-01-01 – 2018-12-31
Current period

USD 40.09 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

40089457 − 30650402 = 9439055 USD

30650402 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
40089457 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · KIWA BIO-TECH PRODUCTS GROUP CORP · 2019-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Year-over-year change in Revenue: 9439055 USD Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 40089457 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#717869 Filing: 000149315220010111 Input fundies:Revenue: 30650402 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#718072 Filing: 000149315220010111
The citation records this snapshot. The page link may show a newer release later.
Net income
-2,029.9%

Prior period

USD 343,821

2018-01-01 – 2018-12-31
Current period

−USD 6.64 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-6635296 − 343821 = -6979117 USD

343821 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-6635296 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2019-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Year-over-year change in Net income: -6979117 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6635296 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#268114 Filing: 000149315220010111 Input fundies:NetIncome: 343821 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#269891 Filing: 000149315220010111
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.83 million

Prior period

−USD 1.65 million

2018-01-01 – 2018-12-31
Current period

USD 183,067

2019-01-01 – 2019-12-31

Exact inputs and evidence

183067 − -1648963 = 1832030 USD

-1648963 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
183067 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2019-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Year-over-year change in Operating cash flow: 1832030 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 183067 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#798232 Filing: 000149315220010111 Input fundies:OperatingCashFlow: -1648963 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#798415 Filing: 000149315220010111
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 40.09 million 100% of revenue
Cost of revenue USD 30.76 million 77% of revenue
Operating expenses USD 10.52 million 26% of revenue
Operating income −USD 1.19 million −3% of revenue
Tax, interest and other Derived USD 5.45 million 14% of revenue
Net income −USD 6.64 million −17% of revenue

Cash

Operating cash flow USD 183,067 0.5% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 2,414% of revenue.
2011 Not shown: operating income or net income is not reported.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2016 Net income was higher than operating income, so the split is not drawn.
2017 Net income was higher than operating income, so the split is not drawn.
2018 92%
2019 Operating loss: operating costs were 103% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	88056	2125839 Derived	-2037783	238000 Derived	-2275783	-983704 Derived	Source 2010-01-01 – 2010-12-31: 88056 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2037783 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -2275783 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -983280 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 424 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	0	1422789 Derived	-1422789	268530 Derived	-1691319	-499807 Derived	Source 2011-01-01 – 2011-12-31: 0 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -1422789 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -1691319 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -499807 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 0 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	0	595559 Derived	-595559	746873 Derived	-1342432	Unavailable	Source 2012-01-01 – 2012-12-31: 0 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -595559 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -1342432 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -242708 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	0	556852 Derived	-556852	-4270718 Derived	3713866	Unavailable	Source 2013-01-01 – 2013-12-31: 0 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -556852 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 3713866 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -138028 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	0	527558 Derived	-527558	179998 Derived	-707556	Unavailable	Source 2014-01-01 – 2014-12-31: 0 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -527558 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -707556 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -143255 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	9620929	8748203 Derived	872726	-18304 Derived	891030	-987810 Derived	Source 2016-01-01 – 2016-12-31: 9620929 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 872726 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 891030 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -908727 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 79083 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	17270069	15473938 Derived	1796131	-3512905 Derived	5309036	-5724436 Derived	Source 2017-01-01 – 2017-12-31: 17270069 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 1796131 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 5309036 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5649151 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 75285 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	30650402	28061056 Derived	2589346	2245525 Derived	343821	-1701955 Derived	Source 2018-01-01 – 2018-12-31: 30650402 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 2589346 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 343821 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -1648963 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 52992 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	40089457	41275235 Derived	-1185778	5449518 Derived	-6635296	Unavailable	Source 2019-01-01 – 2019-12-31: 40089457 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -1185778 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -6635296 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 183067 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 40.1M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	38292	Revenue: 38292 Open source
20102010-12-31	Revenue	88056	Revenue: 88056 Open source
20112011-12-31	Revenue	0	Revenue: 0 Open source
20122012-12-31	Revenue	0	Revenue: 0 Open source
20132013-12-31	Revenue	0	Revenue: 0 Open source
20142014-12-31	Revenue	0	Revenue: 0 Open source
20162016-12-31	Revenue	9620929	Revenue: 9620929 Open source
20172017-12-31	Revenue	17270069	Revenue: 17270069 Open source
20182018-12-31	Revenue	30650402	Revenue: 30650402 Open source
20192019-12-31	Revenue	40089457	Revenue: 40089457 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

30.8% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 38292 Open source
20102010-12-31	Year over year	130%	Revenue: 88056 Open source Revenue: 38292 Open source
20112011-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 88056 Open source
20122012-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20132013-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20142014-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 9620929 Open source
20172017-12-31	Year over year	79.5%	Revenue: 17270069 Open source Revenue: 9620929 Open source
20182018-12-31	Year over year	77.5%	Revenue: 30650402 Open source Revenue: 17270069 Open source
20192019-12-31	Year over year	30.8%	Revenue: 40089457 Open source Revenue: 30650402 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3% 2019

Net margin -16.6% 2019

Free cash flow margin -5.6% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-5,414.5%	Operating Income: -2073310 Open source Revenue: 38292 Open source
20102010-12-31	Operating margin	-2,314.2%	Operating Income: -2037783 Open source Revenue: 88056 Open source
20112011-12-31	Operating margin	Not reported	Operating Income: -1422789 Open source Revenue: 0 Open source
20122012-12-31	Operating margin	Not reported	Operating Income: -595559 Open source Revenue: 0 Open source
20132013-12-31	Operating margin	Not reported	Operating Income: -556852 Open source Revenue: 0 Open source
20142014-12-31	Operating margin	Not reported	Operating Income: -527558 Open source Revenue: 0 Open source
20162016-12-31	Operating margin	9.1%	Operating Income: 872726 Open source Revenue: 9620929 Open source
20172017-12-31	Operating margin	10.4%	Operating Income: 1796131 Open source Revenue: 17270069 Open source
20182018-12-31	Operating margin	8.4%	Operating Income: 2589346 Open source Revenue: 30650402 Open source
20192019-12-31	Operating margin	-3%	Operating Income: -1185778 Open source Revenue: 40089457 Open source
20092009-12-31	Net margin	-9,700.5%	Net Income: -3714529 Open source Revenue: 38292 Open source
20102010-12-31	Net margin	-2,584.5%	Net Income: -2275783 Open source Revenue: 88056 Open source
20112011-12-31	Net margin	Not reported	Net Income: -1691319 Open source Revenue: 0 Open source
20122012-12-31	Net margin	Not reported	Net Income: -1342432 Open source Revenue: 0 Open source
20132013-12-31	Net margin	Not reported	Net Income: 3713866 Open source Revenue: 0 Open source
20142014-12-31	Net margin	Not reported	Net Income: -707556 Open source Revenue: 0 Open source
20162016-12-31	Net margin	9.3%	Net Income: 891030 Open source Revenue: 9620929 Open source
20172017-12-31	Net margin	30.7%	Net Income: 5309036 Open source Revenue: 17270069 Open source
20182018-12-31	Net margin	1.1%	Net Income: 343821 Open source Revenue: 30650402 Open source
20192019-12-31	Net margin	-16.6%	Net Income: -6635296 Open source Revenue: 40089457 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 38292 Open source
20102010-12-31	Free cash flow margin	-1,117.1%	Revenue: 88056 Open source Operating Cash Flow: -983280 Open source Capital Expenditure: 424 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -499807 Open source Capital Expenditure: 0 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -242708 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -138028 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -143255 Open source
20162016-12-31	Free cash flow margin	-10.3%	Revenue: 9620929 Open source Operating Cash Flow: -908727 Open source Capital Expenditure: 79083 Open source
20172017-12-31	Free cash flow margin	-33.1%	Revenue: 17270069 Open source Operating Cash Flow: -5649151 Open source Capital Expenditure: 75285 Open source
20182018-12-31	Free cash flow margin	-5.6%	Revenue: 30650402 Open source Operating Cash Flow: -1648963 Open source Capital Expenditure: 52992 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 40089457 Open source Operating Cash Flow: 183067 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 183.1K 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	-983280	Operating Cash Flow: -983280 Open source
20112011-12-31	Operating cash flow	-499807	Operating Cash Flow: -499807 Open source
20122012-12-31	Operating cash flow	-242708	Operating Cash Flow: -242708 Open source
20132013-12-31	Operating cash flow	-138028	Operating Cash Flow: -138028 Open source
20142014-12-31	Operating cash flow	-143255	Operating Cash Flow: -143255 Open source
20162016-12-31	Operating cash flow	-908727	Operating Cash Flow: -908727 Open source
20172017-12-31	Operating cash flow	-5649151	Operating Cash Flow: -5649151 Open source
20182018-12-31	Operating cash flow	-1648963	Operating Cash Flow: -1648963 Open source
20192019-12-31	Operating cash flow	183067	Operating Cash Flow: 183067 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.7M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	-983704	Operating Cash Flow: -983280 Open source Capital Expenditure: 424 Open source
20112011-12-31	Free cash flow	-499807	Operating Cash Flow: -499807 Open source Capital Expenditure: 0 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -242708 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -138028 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -143255 Open source
20162016-12-31	Free cash flow	-987810	Operating Cash Flow: -908727 Open source Capital Expenditure: 79083 Open source
20172017-12-31	Free cash flow	-5724436	Operating Cash Flow: -5649151 Open source Capital Expenditure: 75285 Open source
20182018-12-31	Free cash flow	-1701955	Operating Cash Flow: -1648963 Open source Capital Expenditure: 52992 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: 183067 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

59.8% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Liabilities / assets	1,964.4%	Total Liabilities: 8357882 Open source Total Assets: 425465 Open source
20102010-12-31	Liabilities / assets	7,961.5%	Total Liabilities: 10504714 Open source Total Assets: 131944 Open source
20112011-12-31	Liabilities / assets	19,696.2%	Total Liabilities: 12408437 Open source Total Assets: 62999 Open source
20122012-12-31	Liabilities / assets	32,936.1%	Total Liabilities: 13848327 Open source Total Assets: 42046 Open source
20132013-12-31	Liabilities / assets	36,285.9%	Total Liabilities: 10336049 Open source Total Assets: 28485 Open source
20142014-12-31	Liabilities / assets	48,229.8%	Total Liabilities: 11871776 Open source Total Assets: 24615 Open source
20162016-12-31	Liabilities / assets	169.7%	Total Liabilities: 10329042 Open source Total Assets: 6084990 Open source
20172017-12-31	Liabilities / assets	46.7%	Total Liabilities: 9333751 Open source Total Assets: 20004586 Open source
20182018-12-31	Liabilities / assets	60.9%	Total Liabilities: 19784528 Open source Total Assets: 32511042 Open source
20192019-12-31	Liabilities / assets	59.8%	Total Liabilities: 14384041 Open source Total Assets: 24069329 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.6× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Current assets / current liabilities	0.03×	Current Assets: 169982 Open source Current Liabilities: 6553102 Open source
20102010-12-31	Current assets / current liabilities	0.01×	Current Assets: 106022 Open source Current Liabilities: 8768262 Open source
20112011-12-31	Current assets / current liabilities	0×	Current Assets: 42677 Open source Current Liabilities: 10593526 Open source
20122012-12-31	Current assets / current liabilities	0×	Current Assets: 26081 Open source Current Liabilities: 12002449 Open source
20132013-12-31	Current assets / current liabilities	0×	Current Assets: 16530 Open source Current Liabilities: 8436384 Open source
20142014-12-31	Current assets / current liabilities	0×	Current Assets: 17243 Open source Current Liabilities: 10000640 Open source
20162016-12-31	Current assets / current liabilities	0.43×	Current Assets: 4472718 Open source Current Liabilities: 10329042 Open source
20172017-12-31	Current assets / current liabilities	2.15×	Current Assets: 19073381 Open source Current Liabilities: 8873669 Open source
20182018-12-31	Current assets / current liabilities	1.6×	Current Assets: 31690093 Open source Current Liabilities: 19784528 Open source
20192019-12-31	Current assets / current liabilities	1.6×	Current Assets: 22835356 Open source Current Liabilities: 14253879 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−USD 2.28 million Exact value Exact value: -2275783 USD 2010-01-01 – 2010-12-31: -2275783 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2010-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: -2275783 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2275783 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#205599 Filing: 000114420412020496 The citation records this snapshot. The page link may show a newer release later.	−USD 983,280 Exact value Exact value: -983280 USD 2010-01-01 – 2010-12-31: -983280 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2010-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -983280 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -983280 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#34217 Filing: 000114420412020496 The citation records this snapshot. The page link may show a newer release later.	USD 424 Exact value Exact value: 424 USD 2010-01-01 – 2010-12-31: 424 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIWA BIO-TECH PRODUCTS GROUP CORP · 2010-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Capital Expenditure: 424 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 424 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#34573 Filing: 000114420412020496 The citation records this snapshot. The page link may show a newer release later.	−USD 983,704 Calculation and evidence -983280 − 424 USD Exact free cash flow: -983704 USD 2010-01-01 – 2010-12-31: -983280 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 424 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2010-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Free cash flow: -983704 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -983280 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#34217 Filing: 000114420412020496 Input fundies:CapitalExpenditure: 424 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#34573 Filing: 000114420412020496 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 1.69 million Exact value Exact value: -1691319 USD 2011-01-01 – 2011-12-31: -1691319 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2011-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: -1691319 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1691319 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420413021719/kwbt-20121231.xml#83367 Filing: 000114420413021719 The citation records this snapshot. The page link may show a newer release later.	−USD 499,807 Exact value Exact value: -499807 USD 2011-01-01 – 2011-12-31: -499807 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2011-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -499807 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -499807 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420413021719/kwbt-20121231.xml#92213 Filing: 000114420413021719 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2011-01-01 – 2011-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIWA BIO-TECH PRODUCTS GROUP CORP · 2011-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#34747 Filing: 000114420412020496 The citation records this snapshot. The page link may show a newer release later.	−USD 499,807 Calculation and evidence -499807 − 0 USD Exact free cash flow: -499807 USD 2011-01-01 – 2011-12-31: -499807 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2011-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Free cash flow: -499807 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -499807 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420413021719/kwbt-20121231.xml#92213 Filing: 000114420413021719 Input fundies:CapitalExpenditure: 0 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420412020496/kwbt-20111231.xml#34747 Filing: 000114420412020496 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 1.34 million Exact value Exact value: -1342432 USD 2012-01-01 – 2012-12-31: -1342432 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2012-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: -1342432 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1342432 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420414019098/kwbt-20131231.xml#537750 Filing: 000114420414019098 The citation records this snapshot. The page link may show a newer release later.	−USD 242,708 Exact value Exact value: -242708 USD 2012-01-01 – 2012-12-31: -242708 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2012-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -242708 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -242708 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420414019098/kwbt-20131231.xml#344494 Filing: 000114420414019098 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	USD 3.71 million Exact value Exact value: 3713866 USD 2013-01-01 – 2013-12-31: 3713866 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2013-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: 3713866 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3713866 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420415039529/kwbt-20141231.xml#544341 Filing: 000114420415039529 The citation records this snapshot. The page link may show a newer release later.	−USD 138,028 Exact value Exact value: -138028 USD 2013-01-01 – 2013-12-31: -138028 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2013-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -138028 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -138028 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000114420415039529/kwbt-20141231.xml#336464 Filing: 000114420415039529 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 707,556 Exact value Exact value: -707556 USD 2014-01-01 – 2014-12-31: -707556 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2014-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: -707556 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -707556 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315216008900/kwbt-20151231.xml#73416 Filing: 000149315216008900 The citation records this snapshot. The page link may show a newer release later.	−USD 143,255 Exact value Exact value: -143255 USD 2014-01-01 – 2014-12-31: -143255 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2014-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -143255 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -143255 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315216008900/kwbt-20151231.xml#371362 Filing: 000149315216008900 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 677,358 Exact value Exact value: -677358 USD 2015-01-01 – 2015-12-31: -677358 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2015-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: -677358 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -677358 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315217013724/kwbt-20161231.xml#144818 Filing: 000149315217013724 The citation records this snapshot. The page link may show a newer release later.	−USD 148,036 Exact value Exact value: -148036 USD 2015-01-01 – 2015-12-31: -148036 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2015-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -148036 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -148036 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315217013724/kwbt-20161231.xml#787734 Filing: 000149315217013724 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	USD 891,030 Exact value Exact value: 891030 USD 2016-01-01 – 2016-12-31: 891030 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2016-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: 891030 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 891030 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315218004295/kwbt-20171231.xml#192688 Filing: 000149315218004295 The citation records this snapshot. The page link may show a newer release later.	−USD 908,727 Exact value Exact value: -908727 USD 2016-01-01 – 2016-12-31: -908727 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2016-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -908727 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -908727 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315218004295/kwbt-20171231.xml#673189 Filing: 000149315218004295 The citation records this snapshot. The page link may show a newer release later.	USD 79,083 Exact value Exact value: 79083 USD 2016-01-01 – 2016-12-31: 79083 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIWA BIO-TECH PRODUCTS GROUP CORP · 2016-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Capital Expenditure: 79083 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 79083 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315218004295/kwbt-20171231.xml#681112 Filing: 000149315218004295 The citation records this snapshot. The page link may show a newer release later.	−USD 987,810 Calculation and evidence -908727 − 79083 USD Exact free cash flow: -987810 USD 2016-01-01 – 2016-12-31: -908727 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 79083 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2016-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Free cash flow: -987810 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -908727 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315218004295/kwbt-20171231.xml#673189 Filing: 000149315218004295 Input fundies:CapitalExpenditure: 79083 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315218004295/kwbt-20171231.xml#681112 Filing: 000149315218004295 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 5.31 million Exact value Exact value: 5309036 USD 2017-01-01 – 2017-12-31: 5309036 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2017-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: 5309036 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5309036 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315219005241/kwbt-20181231.xml#208082 Filing: 000149315219005241 The citation records this snapshot. The page link may show a newer release later.	−USD 5.65 million Exact value Exact value: -5649151 USD 2017-01-01 – 2017-12-31: -5649151 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2017-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -5649151 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5649151 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315219005241/kwbt-20181231.xml#506006 Filing: 000149315219005241 The citation records this snapshot. The page link may show a newer release later.	USD 75,285 Exact value Exact value: 75285 USD 2017-01-01 – 2017-12-31: 75285 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIWA BIO-TECH PRODUCTS GROUP CORP · 2017-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Capital Expenditure: 75285 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 75285 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315219005241/kwbt-20181231.xml#511673 Filing: 000149315219005241 The citation records this snapshot. The page link may show a newer release later.	−USD 5.72 million Calculation and evidence -5649151 − 75285 USD Exact free cash flow: -5724436 USD 2017-01-01 – 2017-12-31: -5649151 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 75285 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2017-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Free cash flow: -5724436 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5649151 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315219005241/kwbt-20181231.xml#506006 Filing: 000149315219005241 Input fundies:CapitalExpenditure: 75285 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315219005241/kwbt-20181231.xml#511673 Filing: 000149315219005241 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 343,821 Exact value Exact value: 343821 USD 2018-01-01 – 2018-12-31: 343821 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2018-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: 343821 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 343821 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#269891 Filing: 000149315220010111 The citation records this snapshot. The page link may show a newer release later.	−USD 1.65 million Exact value Exact value: -1648963 USD 2018-01-01 – 2018-12-31: -1648963 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2018-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: -1648963 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1648963 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#798415 Filing: 000149315220010111 The citation records this snapshot. The page link may show a newer release later.	USD 52,992 Exact value Exact value: 52992 USD 2018-01-01 – 2018-12-31: 52992 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KIWA BIO-TECH PRODUCTS GROUP CORP · 2018-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Capital Expenditure: 52992 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52992 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#569765 Filing: 000149315220010111 The citation records this snapshot. The page link may show a newer release later.	−USD 1.7 million Calculation and evidence -1648963 − 52992 USD Exact free cash flow: -1701955 USD 2018-01-01 – 2018-12-31: -1648963 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 52992 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2018-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Free cash flow: -1701955 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1648963 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#798415 Filing: 000149315220010111 Input fundies:CapitalExpenditure: 52992 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#569765 Filing: 000149315220010111 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 6.64 million Exact value Exact value: -6635296 USD 2019-01-01 – 2019-12-31: -6635296 USD Inspect Net Income Open source Share or cite Citation for Net Income · KIWA BIO-TECH PRODUCTS GROUP CORP · 2019-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Net Income: -6635296 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6635296 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#268114 Filing: 000149315220010111 The citation records this snapshot. The page link may show a newer release later.	USD 183,067 Exact value Exact value: 183067 USD 2019-01-01 – 2019-12-31: 183067 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KIWA BIO-TECH PRODUCTS GROUP CORP · 2019-12-31 KIWA BIO-TECH PRODUCTS GROUP CORP (edgar:1159275) Operating Cash Flow: 183067 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1159275/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 183067 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1159275/000149315220010111/kwbt-20191231.xml#798232 Filing: 000149315220010111 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

95 filings · 2,191 latest values · 2,191 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001159275, 1159275, KWBT, edgar:1159275, kwbt

Also known as KIWA BIO-TECH PRODUCTS GROUP CORP, TINTIC GOLD MINING CO, TINTIE GOLD MINING CO

KIWA BIO-TECH PRODUCTS GROUP CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation